| The impact of pretransplant malnutrition on allogeneic hematopoietic stem cell transplantation outcomes EY Hirose, VC de Molla, MV Gonçalves, AD Pereira, RS Szor, ... Clinical nutrition ESPEN 33, 213-219, 2019 | 23 | 2019 |
| Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation V Heidrich, JS Bruno, FH Knebel, VC de Molla, W Miranda-Silva, ... Frontiers in Immunology 12, 692225, 2021 | 16 | 2021 |
| Disruption of the oral microbiota is associated with a higher risk of relapse after allogeneic hematopoietic stem cell transplantation VC de Molla, V Heidrich, JS Bruno, FH Knebel, W Miranda-Silva, ... Scientific Reports 11 (1), 17552, 2021 | 15 | 2021 |
| Commensal oral microbiota impacts ulcerative oral mucositis clinical course in allogeneic stem cell transplant recipients JS Bruno, V Heidrich, FH Knebel, VC de Molla, CJ Parahyba, ... Scientific reports 12 (1), 17527, 2022 | 9 | 2022 |
| Long-term follow-up of ruxolitinib in the treatment of steroid-refractory chronic graft-versus-host disease AM Ferreira, RS Szor, VC Molla, MC Seiwald, PA de Moraes, ... Transplantation and Cellular Therapy 27 (9), 777. e1-777. e6, 2021 | 7 | 2021 |
| Clinical characteristics of Brazilian patients with paroxysmal nocturnal hemoglobinuria and changing prognosis with eculizumab PE Yamakawa, AR Da Fonseca, IBR Gomes, VC de Molla, AD Pereira, ... Blood 134, 2222, 2019 | 3 | 2019 |
| Current use and outcomes of hematopoietic stem cell transplantation: Brazilian summary slides AJ Simione, HRA das Neves, CC da Silva, PM da Silva Sabaini, ... Journal of Bone Marrow Transplantation and Cellular Therapy 3 (2), 171-171, 2022 | 2 | 2022 |
| Safety and efficacy of venetoclax combined with hypomethylating agents or low-dose cytarabine for acute myeloid leukemia before and after allogeneic hematopoietic cell … RFP Mendes, G Fatobene, V Molla, R Helman, M Rodrigues, ... Biology of Blood and Marrow Transplantation 26 (3), S300, 2020 | 2 | 2020 |
| Subcutaneous Alemtuzumab Has Activity in Treatment-Naïve Patients with Acquired Aplastic Anemia AR Da Fonseca, A Hill, PE Yamakawa, IB Rabelo, AD Pereira, ... Blood 134, 2503, 2019 | 2 | 2019 |
| Longitudinal analysis at three oral sites links oral microbiota to clinical outcomes in allogeneic hematopoietic stem-cell transplant V Heidrich, FH Knebel, JS Bruno, VC de Molla, W Miranda-Silva, ... Microbiology Spectrum 11 (6), e02910-23, 2023 | 1 | 2023 |
| Natural killer cells 56bnght16– have higher counts in the umbilical cord blood than in the adult peripheral blood VC Molla, MCR Barbosa, A Mendrone, MV Gonçalves, EKF Guirao, ... Hematology, Transfusion and Cell Therapy 45 (4), 419-427, 2023 | 1 | 2023 |
| Suspected Germline TP53 Variants and Clonal Hematopoiesis of Indeterminate Potential: Lessons Learned From a Molecular Tumor Board CB Xavier, R Link, L Abreu, F Bettoni, F Marson, PAF Galante, C Masotti, ... The Oncologist 28 (7), 624-627, 2023 | 1 | 2023 |
| Current use and outcomes of hematopoietic stem cell transplantation: Brazilian summary slides-2023 AJ Simione, HRA das Neves, CC da Silva, PM da Silva Sabaini, ... JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY 4 (2), 200-200, 2023 | 1 | 2023 |
| Ikaros expression is associated with an increased risk of chronic graft-versus-host disease AD Pereira, VC de Molla, A Fonseca, L Tucunduva, Y Novis, MS Pires, ... Scientific Reports 13 (1), 8458, 2023 | 1 | 2023 |
| Oral microbiome influences the clinical course of oral mucositis in allogeneic hsct patients JS Bruno, V Heidrich, FH Knebel, VC De Molla, W Miranda-Silva, ... Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 133 (5), e116 …, 2022 | 1 | 2022 |
| Dental biofilm microbiota dysbiosis is associated with the risk of aGVHD after allogeneic HSCT V Heidrich, JS Bruno, FH Knebel, VC de Molla, W Miranda-Silva, ... medRxiv, 2021.02. 04.21251019, 2021 | 1 | 2021 |
| Disruption of the Oral Microbiota Predicts Poor Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation VC de Molla, V Heidrich, J Bruno, F Knebel, W Miranda-Silva, P Asprino, ... Blood 136 (Supplement 1), 44-45, 2020 | 1 | 2020 |
| Increased Risk of for Cytomegalovirus Reactivation after Allogeneic HSCT in T-Cell Depleted Patients VC Molla, R Azevedo, JF Ramos, DB Ponciano, PHA de Moraes, ... Blood 136 (Supplement 1), 36-37, 2020 | 1 | 2020 |
| Ibrutinib Maintenance after Chemoimmunotherapy Is Feasible and Results in Excellent Progression-Free and Overall Survival in Patients with Detectable MRD after Chemoimmunotherapy NR Guedes, AR Da Fonseca, TX Carneiro, VC de Molla, RS Silva, ... Blood 134, 1764, 2019 | 1 | 2019 |
| Classical monocyte deficiency calculated by the mono-index can predict mortality in allogeneic hematopoietic stem cell transplantation patients VC de Molla, MV Goncalves, EY Kimura, V Colturato, MV Ikoma, ... Blood 134, 5666, 2019 | 1 | 2019 |
Paula Fontes AsprinoHospital Sírio-LibanêsE-mail confirmado em mochsl.org.br
